Glorious Moment丨Haibu P¶₩harmaceutical has received multip↔®∞δle honors!

From November 4 to 6, the third Ta•βishan Pharmaceutical Foru♦δ¶ m and the "2023-2024 Annual Pharmaceut×'✔€ical Industry Information Release Conf≥¶∞©erence" were grandly held in∏§ Jinan, Shandong. This forum, th₹£emed "Whole Industry, Big Pl☆ε✘←atform, Deep Integration, Common Deπσ ₽velopment," attracted numerous experts,δφ scholars, and business ↕₽leaders from the phar'§←maceutical industry at home and ☆™™§abroad to discuss the latest developmλε ent trends and technological innovation•‍≥> directions in the pharmaceutical healt♣§© h industry. At this forum, Hai☆∏×♣bu Pharmaceutical receive→ε¶ d multiple honors due to its strengthγ↔↔¥!

Awarded 3 prizes and ret≈✔∞urned with glory

Beijing Haibu Pharmaceutica<→£ l Technology Co., Ltd. was ho≥±₹nored as one of the "Top₩₽≈ Fifty R&D Companies in the Pharma ≤♠ceutical Industry for 2023-2$‌>←024," marking Haibu Phε&✔₹armaceutical's continuous years of'​ receiving this honor.

Ms. Liu Changru, Chairmaα↕$n & General Manager of H÷®♣aibu Pharmaceutical, was awarded≤✔↕> the important title of "Person Promot β$€ing High-Quality Development of↕ε± the Pharmaceutical Health Indφ€€ ustry for 2023-2024."

Haibu Pharmaceutical was awπ​®arded as a "Law-abiding φ☆↓≠and Honest Enterprise i§•n the Pharmaceutical Indus©✔≥✘try for 2023-2024."

Honor is both an aff&∞&irmation and a motivation. In the fu‍→‌ture, Haibu Pharmaceutical wi≠' ↔ll continue to enhance its technicalε≠₩☆ strength, professional level, innova≈‌€tion capability, etc., to pro ×vide customers with higher qualit÷←≠ y products and services while j® ointly welcoming a more brilliant•↔ future for the pharmaceutica©®§l health industry.